Phase II prospective study of the efficacy of gefitinib for the treatment of stage III/IV non-small cell lung cancer with EGFR mutations, irrespective of previous chemotherapy (Q79972356)
Jump to navigation
Jump to search
scientific article published on 26 March 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II prospective study of the efficacy of gefitinib for the treatment of stage III/IV non-small cell lung cancer with EGFR mutations, irrespective of previous chemotherapy |
scientific article published on 26 March 2007 |
Statements
Phase II prospective study of the efficacy of gefitinib for the treatment of stage III/IV non-small cell lung cancer with EGFR mutations, irrespective of previous chemotherapy (English)
Noriaki Sunaga
Yoshio Tomizawa
Noriko Yanagitani
Hironobu Iijima
Kyoichi Kaira
Kimihiro Shimizu
Shigebumi Tanaka
Tatsuo Suga
Takeshi Hisada
Tamotsu Ishizuka
Ryusei Saito
Kunio Dobashi
Masatomo Mori
26 March 2007